In the BioHarmony Drug Report Database
Quinidine gluconate
Duraquin, Quinaglute, Quinidine Gluconate (quinidine gluconate) is a small molecule pharmaceutical. Quinidine gluconate was first approved as Duraquin on 1982-01-01. It is used to treat atrial fibrillation, atrial flutter, and cardiac arrhythmias in the USA. It is known to target potassium channel subfamily U member 1, potassium voltage-gated channel subfamily H member 1, potassium voltage-gated channel subfamily H member 5, potassium voltage-gated channel subfamily A member 5, equilibrative nucleoside transporter 4, and potassium voltage-gated channel subfamily A member 7.
Trade Name
|
Duraquin, Quinaglute, Quinidine Gluconate |
|---|---|
Common Name
|
quinidine gluconate |
ChEMBL ID
|
CHEMBL1200437 |
Indication
|
atrial fibrillation, atrial flutter, cardiac arrhythmias |
Drug Class
|
Image (chem structure or protein)